Page last updated: 2024-10-26

erythrosine and Leukemia, Megakaryoblastic, Acute

erythrosine has been researched along with Leukemia, Megakaryoblastic, Acute in 1 studies

Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.

Leukemia, Megakaryoblastic, Acute: An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.

Research Excerpts

ExcerptRelevanceReference
"In one patient with acute megakaryoblastic leukemia, GM-CSF caused parallel increases in labelling index, Ki-67 positivity and numbers of nucleoside transporters on peripheral blood blast cells."2.67Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter. ( Biggs, JC; Cebon, JS; Gibson, J; Jamieson, GP; McKendrick, JJ; Sheridan, WP; Snook, MB; Szer, J; Wiley, JS; Woodruff, RK, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wiley, JS1
Cebon, JS1
Jamieson, GP1
Szer, J1
Gibson, J1
Woodruff, RK1
McKendrick, JJ1
Sheridan, WP1
Biggs, JC1
Snook, MB1

Trials

1 trial available for erythrosine and Leukemia, Megakaryoblastic, Acute

ArticleYear
Assessment of proliferative responses to granulocyte-macrophage colony-stimulating factor (GM-CSF) in acute myeloid leukaemia using a fluorescent ligand for the nucleoside transporter.
    Leukemia, 1994, Volume: 8, Issue:1

    Topics: Acute Disease; Blood Proteins; Bone Marrow; Bone Marrow Cells; Carrier Proteins; Cell Division; Fluo

1994